SLC6A3 and Parkinson disease: Across these, severe reduction in presynaptic striatal dopamine transporter density in patients with ODS-induced parkinsonism was demonstrated, suggesting damage to the nigrostriatal pathway (159–162), The asymmetry of clinical signs correlated well with asymmetric reduction in uptake of the radiotracer ligand (159–161).